Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2060 of 5804
-
New ultrasound may replace CT scans for injured kids, no radiation needed
Diagnosis Recruiting nowChildren with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some pro…
Phase: PHASE4 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Massive study tests if daily pills keep bones strong
Prevention CompletedThe VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
New study tests best methods to prevent blindness in rural areas
Knowledge-focused CompletedThe vast majority of blindness is avoidable. The World Health Organization (WHO) estimates that 80% of cases of visual impairment could be prevented or reversed with early diagnosis and treatment. The leading causes of visual impairment are cataract and refractive error, followed…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Catheter or surgery? new study seeks best way to ease breathing in cancer patients
Symptom relief CompletedThe purpose of this study is to determine if an indwelling catheter is more effective than surgical pleurodosis in treating malignant pleural effusion. Who is it for? You may be eligible for this study if you are an adult who is suffering from symptomatic proven pleural maligna…
Phase: NA • Sponsor: The University of Western Australia • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Alcohol gel vs steroid: which injection eases disc pain longer?
Symptom relief Recruiting nowDISCOGEL® is on the market since 2007. About 20,000 kits were sold to date (October 2017). The device re-obtained its CE mark in 2017. A clinical evaluation was performed by bibliographic route in 2016. Clinical data on more than 600 patients treated by DISCOGEL® were analyzed. …
Phase: NA • Sponsor: Gelscom SAS • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
770 cancer patients join study to unlock immunotherapy secrets
Knowledge-focused Recruiting nowThis is a translational, open-label, multi-site, prospective cohort study aiming to identify and to monitor immunological biomarkers associated with therapeutic response to immune checkpoints blockade (ICB), in patients with multiple types of advanced (unresectable and/or metasta…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tiny paclitaxel particles aim to hit tumors harder
Disease control OngoingThis phase I trial studies the side effects and best dose of PEOX-based polymer encapsulated paclitaxel FID-007 (FID-007) in treating participants with malignant neoplasms that have spread to other places in the body and do not respond to treatment. FID-007 is a packaged form of …
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Your genes, your diet: a new way to stop diabetes?
Knowledge-focused CompletedWith this study the investigators want to understand the physiological differences for people developing pre-diabetes and diabetes. The investigators hypothesize that different individuals go through different paths in the development of the disease. By understanding the personal…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Hunterase extended trial shows promise for managing hunter syndrome
Disease control CompletedThe objective of this study is to assess the long-term safety and efficacy of Hunterase for approximately 1 year in subjects who completed the end of study (EOS) visit (Visit 54) tests in the Phase 3 Hunterase study and patients who received Hunterase for more than 6 months
Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can cuddling save tiny babies? trial tests early kangaroo care
Disease control TerminatedThe mortality effect of kangaroo mother care in stable newborns \<2000g is well established but mortality effect in unstable newborns is not conclusively known. This pragmatic clinical trial aims to investigate the mortality and clinical effects of early continuous Kangaroo Mothe…
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Personalized brain zaps plus therapy shows promise for depression
Symptom relief CompletedBackground: Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. It stimulates the brain. Researchers want to see if using magnetic resonance imaging (MRI) scans helps locate the best area for rTMS in each person. They also want to find other ways t…
Phase: NA • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can stem cells repair a scarred liver? new trial hopes so
Disease control ENROLLING_BY_INVITATIONThe study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can a drug shrink precancerous breast cells before surgery?
Disease control CompletedThis study is evaluating how ruxolitinib affects premalignant breast cells. One half of the study participants will receive ruxolitinib for approximately 15 days, and the other half will receive a placebo (sugar pill) for approximately 15 days. Once study participants have comple…
Phase: PHASE2 • Sponsor: Julie Nangia • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New scan may better spot ovarian cancer tumors before surgery
Diagnosis OngoingThis trial studies how well positron emission tomography/magnetic resonance (PET/MR) versus contrast enhanced computerized tomography (CECT) scans work in locating ovarian cancer tumors in patients with known or suspected ovarian cancer. PET, MR, and CECT scans use different meth…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Can exercise, diet, or a pill help older diabetics stay strong?
Disease control CompletedPrimary objective: To assess the effects of a modified plant-based Mediterranean diet (vegeterranean diet), circuit resistance training (CRT) and empagliflozin alone or in combination on metabolic and physical function in elderly subjects with type 2 diabetes. The rationale for t…
Phase: PHASE4 • Sponsor: Tel-Aviv Sourasky Medical Center • Aim: Disease control
Last updated Jun 26, 2026 14:21 UTC
-
New drug shows promise for Long-Term control of cushing syndrome
Disease control OngoingThis is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully completed participation in a Corcept-sponsored study of relacorilant and may benefit from continuing treatment.
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Personalized weight loss: Gene-Tailored drug shows promise
Disease control CompletedObesity is a widespread disease with increasing prevalence and associated with serious secondary complications. So far, the origin of the disease, regardless of an existing positive energy balance, is not fully understood. In addition to environmental factors, the genetic backgro…
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Momelotinib access expanded for myelofibrosis patients in Long-Term safety study
Disease control OngoingThe primary objective of this study is to provide extended access and assess long-term safety of momelotinib (MMB) in participants with primary myelofibrosis (PMF) or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (Post-PV/ET MF) enrolled in studies GS-US-…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Belly wall transplants: a new frontier in organ transplants?
Disease control Recruiting nowThe purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain scan study seeks clues to memory decline in older adults
Knowledge-focused Recruiting nowThe purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline.…
Phase: PHASE3 • Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC